Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface

Details for Australian Patent Application No. 2005249553 (hide)

Owner Sidney Kimmel Cancer Center

Inventors Oh, Philip; Schnitzer, Jan E.

Agent Spruson & Ferguson

Pub. Number AU-B-2005249553

PCT Pub. Number WO2005/117999

Priority 60/576,192 02.06.04 US

Filing date 2 June 2005

Wipo publication date 15 December 2005

Acceptance publication date 11 February 2010

International Classifications

A61K 51/08 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2005/117999 Priority application(s): WO2005/117999

11 February 2010 Application Accepted

  Published as AU-B-2005249553

3 June 2010 Assignment before Grant

  Sidney Kimmel Cancer Center The application has been assigned to Schnitzer, Jan

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249555-Technical field of the invention

2005249546-Method and system for solubilizing protein